Streetwise Reports (04/07/2026)
Alto Neuroscience Inc. (ANRO:NYSE) pivots after mixed trial results, targeting treatment-resistant depression with analyst support and major market growth potential. Research Report
Dr. Ananda Ghosh (04/07/2026)
H.C. Wainwright reiterated its rating and price target on Maze Therapeutics (MAZE:NASDAQ), following KOL calls that validated the HORIZON Phase 2 dataset as biologically coherent, confirmed the diabetic cohort signal as drug-attributable proof of concept, and outlined a clear path to pivotal trials. Streetwise Reports (04/07/2026)
Rackla Metals Inc. (RAK:TSX.V) finds high-grade tungsten potential in Yukon, leveraging historic data and surging demand for a major breakthrough opportunity. Contributed Opinion
Stephen McBride (04/06/2026)
Stephen McBride of RiskHedge explains why you shouldn't lose all faith in Nvidia Corp. (NVDA:NASDAQ) just yet. Streetwise Reports (04/06/2026)
Algo Grande Copper Corp. (ALGR:TSX.V) reveals a large copper-silver-gold skarn system in Sonora, with porphyry upside and Phase 2 drilling set to drive growth. Contributed Opinion
Michael Ballanger (04/06/2026)
Michael Ballanger of GGM Advisory Inc. shares his view on the current state of the markets, specifically looking at oil.